Power to the Patients is a LinkedIn Live and podcast series hosted by Power where clinical research leaders across sponsors, sites, CROs, and patient advocacy groups discuss patient centricity in clinical trials. We explore the bottlenecks in today's systems, challenge the status quo and talk about future opportunities for innovation.
Looking for a clinical trial? Visit us at www.withpower.com
John Krystal, Chair of the Department of Psychiatry at Yale, joins Brandon Li to discuss his groundbreaking work on ketamine's antidepressant effects and the evolving landscape of psychiatric treatme…
In this episode, Brandon sits down with Shawn Singh, CEO of Vistagen, to discuss a first-of-its-kind approach to treating mental health conditions. Vistagen is developing pherines, a new class of nas…
In this episode, Brandon sits down with Shawn Singh, CEO of Vistagen, to discuss a first-of-its-kind approach to treating mental health conditions. Vistagen is developing pherines, a new class of nas…
In this episode, Brandon Li sits down with Dr. Jordan Smoller - Jerrold F. Rosenbaum Chair in Psychiatry at Mass General, Co-Director for the Center for Suicide Research and Prevention at MGH and Har…
In this episode, Brandon Li sits down with Dr. Jordan Smoller - Jerrold F. Rosenbaum Chair in Psychiatry at Mass General, Co-Director for the Center for Suicide Research and Prevention at MGH and Har…
How do we move from a system that treats disease to a system that cares for individuals? Dr. Anthony Yanni, Senior Vice President and Global Head of Patient Centricity at Astellas Pharma Inc, has spe…
How do we move from a system that treats disease to a system that cares for individuals? Dr. Anthony Yanni, Senior Vice President and Global Head of Patient Centricity at Astellas Pharma Inc, has spe…
In this episode, Brandon Li sits down with Raymond Sanchez, former CMO of Cerevel, now at Bain Capital Life Sciences, to discuss the neuroscience renaissance—the explosion of new treatments, novel me…
In this episode, Brandon Li sits down with Raymond Sanchez, former CMO of Cerevel, now at Bain Capital Life Sciences, to discuss the neuroscience renaissance—the explosion of new treatments, novel me…
On this episode of Power to the Patients, we are joined by Amit Etkin, Founder & CEO of Alto Neuroscience and adjunct professor at Stanford, to explore how precision psychiatry is paving the way for …
On this episode of Power to the Patients, we are joined by Amit Etkin, Founder & CEO of Alto Neuroscience and adjunct professor at Stanford, to explore how precision psychiatry is paving the way for …
In this episode, Brandon Li speaks with Kabir Nath, CEO of Compass Pathways, about their groundbreaking work in using psilocybin for treatment-resistant depression (TRD). Kabir shares his personal co…
In this episode, Brandon Li speaks with Kabir Nath, CEO of Compass Pathways, about their groundbreaking work in using psilocybin for treatment-resistant depression (TRD). Kabir shares his personal co…
In this episode, Brandon Li sits down with Manish Agrawal, Co-Founder and CEO of Sunstone Therapies, to discuss the transformative role of psychedelics in cancer care and mental health.
Manish share…
In this episode, Brandon Li sits down with Manish Agrawal, Co-Founder and CEO of Sunstone Therapies, to discuss the transformative role of psychedelics in cancer care and mental health.
Manish share…
In this episode, Brandon Li sits down with Srinivas Rao, Co-CEO of atai Life Sciences, for a deep dive into the pragmatic strategies shaping the future of psychedelic therapies. Srini shares how his …
In this episode, Brandon Li sits down with Srinivas Rao, Co-CEO of atai Life Sciences, for a deep dive into the pragmatic strategies shaping the future of psychedelic therapies. Srini shares how his …
In this episode, Jessica Branning, President of JBran Consulting and former CEO of ClinCloud, shares her work in creating accessible and patient-focused clinical research sites in the neuropsych spa…